BiotechTube
Home/Propanc Biopharma/Jeannine Zimmerman
JZ

Jeannine Zimmerman

Chief Financial Officer

Propanc Biopharma

Therapeutic Areas

OncologySolid Tumors

Propanc Biopharma Pipeline

DrugIndicationPhase
PRPAdvanced Solid Tumors (Pancreatic, Ovarian, Colorectal)Phase 1/2

Leadership Team at Propanc Biopharma

JN
James Nathanielsz
CEO and Executive Chairman
PD
Prof. Dr. Klaus Kutz
Chief Medical Officer
DR
Dr. Ralf Brandt
Research & Development Director
View full Propanc Biopharma profile